V030-4507 Screening compound: N~1~-(3-ethyl-1,1-dioxo-4-phenyl-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin-7-yl)-1-cyclobutanecarboxamide

V030-4507 Screening compound: N~1~-(3-ethyl-1,1-dioxo-4-phenyl-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin-7-yl)-1-cyclobutanecarboxamide
V030-4507 Screening compound: N~1~-(3-ethyl-1,1-dioxo-4-phenyl-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin-7-yl)-1-cyclobutanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-4507
N~1~-(3-ethyl-1,1-dioxo-4-phenyl-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin-7-yl)-1-cyclobutanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-4507

Molecular Formula

C20H21N3O3S (C20 H21 N3 O3 S)

Compound Name

N~1~-(3-ethyl-1,1-dioxo-4-phenyl-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin-7-yl)-1-cyclobutanecarboxamide

IUPAC name

N-(3-ethyl-11-dioxo-4-phenyl-4H-1lambda624-benzothiadiazin-7-yl)cyclobutanecarboxamide

SMILES

CCC(N(c1ccccc1)c(cc1)c2cc1NC(C1CCC1)=O)=NS2(=O)=O

InChI

InChI=1S/C20H21N3O3S/c1-2-19-22-27(25,26)18-13-15(21-20(24)14-7-6-8-14)11-12-17(18)23(19)16-9-4-3-5-10-16/h3-5,9-14H,2,6-8H2,1H3,(H,21,24)

InChI Key

XGQVAQCDDQFRSX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20499898

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

383.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.149

Distribution Coefficient, logD

2.148

Water Solubility, LogSw

-2.89

Polar Surface Area

66.422

Acid Dissociation Constant (pKa)

10.48

Base Dissociation Constant (pKb)

3.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

V030-4507 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with V030-4507 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-4507?
Check Price and Availability of V030-4507, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-4507 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-4507
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-4507
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-4507 available by request